FDA Drug Application (021906) for KALETRA by ABBVIE

Back to FDA Applications sponsored by ABBVIE

Application Number021906
Product Number001
FormTABLET;ORAL
Dosage200MG;50MG
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code
Reference Drug
Drug NameKALETRA
Active IngredientLOPINAVIR; RITONAVIR



Back to FDA Applications sponsored by ABBVIE

Problems, Comments, Suggestions? Click here to contact Greg Thatcher

Please read my Disclaimer





Copyright (c) 2013 Thatcher Development Software, LLC. All rights reserved. No claim to original U.S. Gov't works.